Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

WNS

WNS Shareholders Overwhelmingly Approve Capgemini Acquisition

WNS (Holdings) Limited (NYSE: WNS) has announced that its shareholders have overwhelmingly approved the acquisition by Capgemini SE (EUR: CAP) at a special court-ordered meeting and general meeting held on August 29, 2025. Approximately 99.9% of the shares voted were cast in favor of the transaction, representing approximately 79.2% of WNS' total outstanding shares as of the voting record date.

The acquisition, which was announced on July 7, 2025, entails Capgemini acquiring WNS for a cash consideration of $76.50 per WNS share, totaling $3.3 billion, excluding WNS net financial debt. The transaction is expected to close prior to the end of the calendar year, subject to the satisfaction of customary closing conditions and regulatory approvals.

In response to the shareholder approval, Keshav R. Murugesh, Chief Executive Officer of WNS, expressed his pleasure with the results and thanked shareholders for their strong support of the combination. He highlighted the potential of the combined entity, stating that together, WNS and Capgemini will combine deep domain-centric operations with cutting-edge technologies to enable clients to unlock strategic value and outperform their competition.

As of June 30, 2025, WNS had 66,085 professionals across 65 delivery centers worldwide, including facilities in Canada, China, Costa Rica, India, Malaysia, the Philippines, Poland, Romania, South Africa, Sri Lanka, Turkey, the United Kingdom, and the United States.

The final voting results of the court meeting and the general meeting can be found in a form 8-K filed with the U.S. Securities and Exchange Commission. As a result of these announcements, the company's shares have moved -0.05% on the market, and are now trading at a price of $75.45. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS